Compare
Lilly (Eli) vs PTC Therapeutics (LLY vs PTCT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Lilly (Eli) (LLY) returned +46.2% and PTC Therapeutics (PTCT) -8.8%; so far this year the figures are +26.0% and -13.8%.
Lilly (Eli) is the larger company by market value, about 232.9 times the size of PTC Therapeutics.
Revenue grew +45.5% at LLY and -35.1% at PTCT over the last year.
LLY yields 0.49%. PTCT pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| LLY | PTCT | |
|---|---|---|
| Price | $1,354.00 | $65.44 |
| 1-day | -0.79% | -0.35% |
| YTD | +25.99% | -13.85% |
| 1 year | +46.25% | -8.82% |
| 3 years | +144.20% | +254.69% |
| Market cap | $1.27T | $5.5B |
| P/E | 43.9 | — |
| P/S | 14.73 | 4.73 |
| P/B | 31.63 | — |
| Revenue growth | +45.50% | -35.10% |
| EPS growth | +50.70% | -116.40% |
| Gross margin % | 83.6 | 25.5 |
| Net margin % | 31.9 | -9.2 |
| ROE % | 68.5 | — |
| Debt / equity | 1.23 | — |
| FCF yield % | 2.4 | 0.0 |
| Dividend yield % | 0.49 | — |
| Beta | 0.29 | 0.82 |
| RSI (14) | 61.1 | 53.3 |
| Technical rating |